Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

7 reasons why DTC drug marketing will decline in 2013

Richard Meyer
Meds
March 30, 2013
Share
Tweet
Share

shutterstock_118348960

According to a new report from Cegedim Strategic Data, DTC promotional spending declined 22% versus last year. In fact they reported that “spending in nearly every channel saw decline year over year in 2012, the only exception being direct mail, which continued an upward trend.  Here are the reasons why I expect DTC marketing to continue to decline in 2013.

1. Most big brands are coming off patent. Pfizer is already looking for someone to spearhead the switch of Nexium to OTC and Lilly’s Cymbalta comes off patent next year.  The model of replacing “new and improved” versions of popular drugs is being challenged by payers who want clinical proof that it is better than generics.

2. Big pharma companies are getting squeezed by a changing healthcare environment. It not only costs more to develop and market new drugs the FDA often asks for more studies shortening the time the pharma company has exclusivity.

3. Changing demographics. We are seeing a changing of the guard as boomers turn 65 at the rate of about 10,000 per day.  Unlike previous generations Boomers challenge everything and want to make informed and educated decisions about healthcare. They still trust their doctors but want to know why and how before treatment.

4. Pharma ignores empowered patients. As my previous post indicated when it comes to digital marketing pharma is lagging way behind other industries and shows no signs of wanting to catch up by building digital marketing capabilities.  Patients are embracing the internet for health but pharma is stuck in a model of search marketing and websites with some digital ads here and there.  There is also a wide spread belief that digital marketing is less expensive that other marketing channels when we know that is not true.

5. Lack of talent. In case you haven’t noticed a lot of talented marketing people are leaving the pharma industry because legal and regulatory people have all but killed any attempt at two way marketing.  At the same time executives are asking for proof that DTC marketing works and want a direct connection between money spent and results.

6. TV is becoming more and more ineffective. If you believe that someone is going to see an ad for your product and run to their doctor to ask for it there is some swamp land I would like to sell you.  More and more people are multitasking while watching TV and they aren’t paying attention to your ads.

7. Consumers are smarter than DTC marketers. A great example are the stories recently about how some diabetes drugs can cause an pancreatic problems.  Where are the drug makers to explain and clarify this information ?

This has been coming for a long long time and unless DTC marketers wake up they are going to find budgets cuts even more severely.  Time to bring pharma marketing into the 21st century.

Richard Meyer is Executive Director/Principal at Online Strategic Solutions and blogs at World of DTC Marketing.com.

Image credit: Shutterstock.com

Prev

Make small bets during the era of health reform

March 29, 2013 Kevin 3
…
Next

It's our duty as physicians to avoid needless tests

March 30, 2013 Kevin 11
…

Tagged as: Medications

Post navigation

< Previous Post
Make small bets during the era of health reform
Next Post >
It's our duty as physicians to avoid needless tests

ADVERTISEMENT

More by Richard Meyer

  • a desk with keyboard and ipad with the kevinmd logo

    Mobile health apps don’t always follow conventional wisdom

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    How can pharma earn the trust of patients?

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    Celebrity endorsements of prescription drugs

    Richard Meyer

More in Meds

  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • The food-drug interaction risks your doctor may be missing

    Frank Jumbe
  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • 5 blind spots that stall physician wealth

      Johnny Medina, MSc | Finance
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician
    • How veteran health care is being transformed by tech and teamwork

      Deborah Lafer Scher | Conditions
    • Why judgment is hurting doctors—and how mindfulness can heal

      Jessie Mahoney, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 6 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • 5 blind spots that stall physician wealth

      Johnny Medina, MSc | Finance
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician
    • How veteran health care is being transformed by tech and teamwork

      Deborah Lafer Scher | Conditions
    • Why judgment is hurting doctors—and how mindfulness can heal

      Jessie Mahoney, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

7 reasons why DTC drug marketing will decline in 2013
6 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...